ReviewFuture medicinal chemistry2024

Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors.

Qiangfeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.